LUISI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 13.507
EU - Europa 10.220
AS - Asia 1.914
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 13
SA - Sud America 13
Totale 25.698
Nazione #
US - Stati Uniti d'America 13.460
GB - Regno Unito 3.242
IE - Irlanda 1.821
CN - Cina 1.370
UA - Ucraina 1.247
SE - Svezia 804
RU - Federazione Russa 712
IT - Italia 621
DE - Germania 614
FR - Francia 607
SG - Singapore 366
FI - Finlandia 331
ES - Italia 73
TR - Turchia 64
BE - Belgio 42
CA - Canada 38
VN - Vietnam 29
CZ - Repubblica Ceca 20
IR - Iran 17
IN - India 15
NL - Olanda 15
AU - Australia 13
BG - Bulgaria 10
EU - Europa 10
JP - Giappone 8
HK - Hong Kong 7
HU - Ungheria 7
RO - Romania 7
ID - Indonesia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
LV - Lettonia 5
MX - Messico 5
PK - Pakistan 5
PL - Polonia 5
AR - Argentina 4
BR - Brasile 4
CH - Svizzera 4
CI - Costa d'Avorio 4
CL - Cile 4
GR - Grecia 4
LT - Lituania 4
MD - Moldavia 4
AT - Austria 3
EE - Estonia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BN - Brunei Darussalam 2
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
CR - Costa Rica 1
CY - Cipro 1
IM - Isola di Man 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 25.698
Città #
Southend 3.037
Fairfield 2.277
Dublin 1.807
Houston 1.031
Jacksonville 1.018
Chandler 989
Woodbridge 963
Ashburn 926
Wilmington 843
Seattle 833
Cambridge 718
Ann Arbor 605
Santa Clara 570
Nanjing 362
Princeton 352
Siena 308
Singapore 274
Beijing 207
Boardman 144
San Diego 141
San Mateo 126
Helsinki 121
Nanchang 114
Moscow 84
Shenyang 75
Tianjin 65
Hebei 64
Menlo Park 63
Málaga 63
New York 63
Düsseldorf 56
Dearborn 55
Kunming 54
Izmir 50
Shanghai 49
Jiaxing 47
Changsha 46
Ningbo 43
Venezia 43
London 42
Jinan 40
Norwalk 39
Brussels 37
Lancaster 37
Hangzhou 30
San Francisco 28
Falls Church 27
Dong Ket 26
Florence 24
Redwood City 23
Zhengzhou 23
Toronto 22
Taizhou 20
Milan 16
Los Angeles 15
Changchun 14
Lanzhou 14
Brno 13
Guangzhou 12
Munich 12
Washington 12
Fremont 11
Hounslow 11
Philadelphia 11
Amsterdam 10
Sofia 9
Hefei 7
Tokyo 7
Atlanta 6
Ottawa 6
Prato 6
Rome 6
Saint Petersburg 6
Tappahannock 6
Zanjan 6
Andover 5
Ankara 5
Boydton 5
Budapest 5
Chiswick 5
Edinburgh 5
Frankfurt am Main 5
Indiana 5
Leawood 5
Paris 5
Phoenix 5
Prague 5
Prescot 5
Riga 5
Stockholm 5
Sydney 5
Abidjan 4
Augusta 4
Cerveteri 4
Charlotte 4
Copenhagen 4
Falkenstein 4
Fuzhou 4
Las Vegas 4
Louvain 4
Totale 19.436
Nome #
Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns 244
Surgical treatment affects perceived stress differently in women with endometriosis: Correlation with severity of pain 238
Endometriosis: seeking optimal management in women approaching menopause 228
Autophagy is upregulated in ovarian endometriosis: A possible interplay with p53 and heme oxygenase-1 220
Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms 216
Hormonal therapy for endometriosis: from molecular research to bedside 213
Parenterally Administered Moderate Sedation and Paracervical Block Versus General Anesthesia for Hysteroscopic Polypectomy: A Pilot Study Comparing Postoperative Outcomes 205
Expression, localization and control of activin A release from human umbilical vein endothelial cells 202
Adenomyosis: What the Patient Needs 198
Yolk sac tumor in a young girl: a case report 191
Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats 190
How to manage bowel endometriosis: The ETIC approach 187
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 185
Dermoscopic and reflectance confocal microscopy features of two cases of vulvar basal cell carcinoma 182
Premature ovarian insufficiency: From pathogenesis to clinical management 174
Naproxen sodium decreases prostaglandins secretion from cultured human endometrial stromal cells modulating metabolizing enzymes mRNA expression 173
When more is not better: 10 'don'ts' in endometriosis management. An ETIC* position statement 171
Ovarian Endometrioma: What the Patient Needs 169
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 165
Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma 161
Mood disorders and quality of life in polycystic ovary syndrome 161
Neuroendocrine aspects of placenta and pregnancy 159
Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology 156
Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro 155
Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A 152
Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study 151
Abnormal umbilical artery Doppler waveforms and cord blood inhibin a and inhibin B levels 150
Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two cases report 149
Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment 147
Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy 146
Activin a plasma levels at birth: an index of fetal hypoxia in preterm newborn 146
Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion 144
Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness 144
Serum allopregnanolone levels relate to FSFI score during the menstrual cycle 143
Sexual pain in women: Quality of sex life and marital relations 143
Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment 143
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 142
Increased serum inhibin B levels in postmenopausal women with altered thyroid function 141
Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation 141
Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women 140
Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa 140
Listeriosis in pregnancy: a case report 139
Oral contraceptives after myomectomy: a short term trial 139
Chronic pelvic pain and quality of life in women with and without endometriosis 138
Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome 138
Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies 137
Single serum activin a testing to predict ectopic pregnancy 136
Panic disorder in menopause: a case control study 136
Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis 135
Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy 134
Surgical scar endometriosis after Cesarean section: a case report 134
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge? 134
Activin A stimulates insulin secretion in cultured human pancreatic islets 134
Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy 133
Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age 133
Activin a Stimulates Interleukin 8 and Vascular Endothelial Growth Factor Release From Cultured Human Endometrial Stromal Cells: Possible Implications for the Pathogenesis of Endometriosis 133
Post-ictal circulating levels of allopregnanolone in children with partial or generalized seizures 133
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis 133
Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause 132
Paroxetine increases brain-derived neurotrophic factor in postmenopausal women 131
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 131
Human placenta as a source of neuroendocrine factors 130
Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors 130
Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery 130
Serum allopregnanolone in women with postpartum “blues” 129
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia 129
Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein 129
Markers biochimici di insufficienza e senescenza placentare 129
Ogilvie's Syndrome in an obstetric patients 128
Increased response of plasma allopregnanolone to corticotropin-releasing hormone in obese patients 128
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats 127
Neuropeptides, neurotransmitters, neurosteroids, and the onset of puberty 127
Overweight and lower age at menarche: Evidence from the Italian HBSC cross-sectional survey 11 Medical and Health Sciences 1117 Public Health and Health Services 127
Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea 126
Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis 125
Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis 125
Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats 124
Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty 124
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats 124
Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women 124
Increased expression of neurogenic factors in uterine fibroids 124
Endometrial expression of relaxin and relaxin receptor in endometriosis 123
Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding 122
Inhibins and activins in pregnancy 122
Total inhibin is a potential serum marker for epithelial ovarian cancer. 122
Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program 122
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy 122
Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats 120
Expression and secretion of activin A: possible physiological and clinical implications 120
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 120
Activin, inhibin and the human breast 120
Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women 120
Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children 120
Hormone replacement therapy in menopause and in premature ovarian insufficiency 119
Endometriosis in Italy: From cost estimates to new medical treatment 119
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment 119
Modern operative hysteroscopy 119
Maternal position during non-stress test and fetal heart rate patterns 119
High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer 119
Serum and tissue expression of activin a in postmenopausal women with breast cancer 119
Totale 14.523
Categoria #
all - tutte 88.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.012 0 0 0 0 0 450 437 691 462 450 178 344
2020/20213.955 228 433 106 401 189 404 168 620 501 323 370 212
2021/20222.750 205 346 165 141 151 80 134 298 173 217 247 593
2022/20233.751 238 195 523 550 396 806 37 348 390 94 107 67
2023/20242.304 119 54 176 95 66 681 858 47 5 29 11 163
2024/20251.758 96 265 405 243 550 199 0 0 0 0 0 0
Totale 25.855